ClinicalTrials.Veeva
Menu

Find clinical trials for Ovarian Cancer in Seattle, WA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Ovarian Epithelial Carcinoma
Cancer
Carcinoma
Endometrial Cancer
Fallopian Tube Cancer
Breast Cancer
Triple Negative Breast Cancer

Ovarian Cancer trials near Seattle, WA, USA:

A Trial of Vigil for Participants With Ovarian Cancer (VITAL)

The goal of this clinical trial is to compare participants with ovarian, fallopian tube or primary peritoneal cancer when treated w...

Active, not recruiting
Ovarian Neoplasms
Ovarian Cancer
Other: Placebo
Biological: Vigil

Phase 2

Gradalis

Tacoma, Washington, United States and 25 other locations

(CAR) T cells developed by Precigen, Inc.) in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that has...

Active, not recruiting
Stage IIIC Ovarian Cancer AJCC v8
Stage IIIA Ovarian Cancer AJCC v8
Biological: PRGN-3005 UltraCAR-T cells

Phase 1

Precigen

Seattle, Washington, United States and 1 other location

This is a multi-center, open-label phase 1 dose escalation trial that uses a modified 3+3 design to identify a recommended phase 2 dose (RP2D) of AB-...

Active, not recruiting
Ovarian Neoplasms
Abdominal Neoplasm
Biological: AB-1015

Phase 1

ArsenalBio

Seattle, Washington, United States and 9 other locations

This study is to be performed as an open label, multicenter, single arm study of 2X-121 to evaluate anti-tumor efficacy of 2X-121 as single ...

Active, not recruiting
Advanced Ovarian Cancer
Drug: 2X-121
Device: 2X-121 DRP®

Phase 2

Allarity Therapeutics

Seattle, Washington, United States and 4 other locations

within each cohort-specific supplement in participants with ovarian, fallopian tube, or primary peritoneal cancer. Cohort A (single ...

Active, not recruiting
Ovarian Neoplasms
Drug: Paclitaxel
Drug: Niraparib

Phase 2

Tesaro
Tesaro

Seattle, Washington, United States and 32 other locations

outcome of ADP A2M4CD8 as monotherapy and in combination treatment with nivolumab in human leukocyte antigen (HLA) A2+ subjects with recurrent ovarian...

Enrolling
Ovarian Cancer
Genetic: Autologous genetically modified ADP-A2M4CD8 cells
Combination Product: Autologous genetically modified ADP-A2M4CD8 cells in combination with Nivolumab

Phase 2

Adaptimmune

Seattle, Washington, United States and 27 other locations

Ovarian cancer is a heterogeneous disease, characterized by complex molecular and genetic changes. The high expression of vascular ...

Active, not recruiting
Ovarian Neoplasms
Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma
Drug: Dostarlimab-Placebo
Drug: Standard of care

Phase 3

Tesaro
Tesaro

Seattle, Washington, United States and 202 other locations

of sovilnesib at different dose levels to establish the Recommended Phase 2 Dose (RP2D) of sovilnesib in subjects with high grade serous ovarian...

Enrolling
Fallopian Tube Cancer
Primary Peritoneal Carcinoma
Drug: Sovilnesib

Phase 1

Volastra Therapeutics

Seattle, Washington, United States and 5 other locations

The primary objective is to evaluate in participants with high-grade serous ovarian cancer (HGSOC), whether the reduction from base...

Active, not recruiting
High-grade Serous Ovarian Carcinoma
Ovarian Carcinoma
Biological: Pembrolizumab
Drug: Carboplatin

Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Seattle, Washington, United States and 44 other locations

This study aims to assess efficacy of Niraparib (GSK3985771) as maintenance treatment in participants with Stage III or IV ovarian cancer...

Active, not recruiting
Ovarian Neoplasms
Drug: Placebo
Drug: Niraparib

Phase 3

Tesaro
Tesaro

Seattle, Washington, United States and 196 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems